Note: The ECOG-ACRIN Cancer Research Group is participating in the Lung Cancer Master Protocol (Lung-MAP), a unique collaborative trial to establish a National Clinical Trials Network mechanism for genomically screening large but homogeneous cancer populations and matching the genomic profile of a patient’s tumor with a biomarker-driven substudy. Substudies compare new targeted therapy or targeted therapy combinations to standard care therapy.
Physician and Research Staff Educational Materials:
These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.
Information and Assistance from the National Cancer Institute:
Additional Information on Lung-MAP.org: Displayed below is an interactive view of the dedicated website for Lung-MAP. If you are experiencing technical difficulties with this view, visit lung-map.org.